ISG15 promotes M5-induced hacat cell proliferation through Wnt signaling in psoriasis

Abstract

Objective Psoriasis is a common chronic, recurrent, immune-mediated inflammatory skin disease, which tends to occur in cold areas. Its pathogenesis is currently unclear. This study aims to screen differentially expressed genes in the psoriasis dataset, identify the central genes, detect the expression of central genes in psoriasis lesions of patients in the cold regions and then conduct further research. Methods Differential genes associated with psoriasis in the GEO database were analyzed, and functional enrichment analysis and protein-protein interaction network analysis. The expression results of the identified genes were validated in psoriasis cell models. The ISG15 gene, which showed the most significant difference in expression, was further studied. The expression level of ISG15 protein in psoriasis was examined. Then, we knocked out ISG15 in psoriasis cell models and detected keratinocyte proliferation by MTT, Real-Time PCR and Western Blot. Western Blot showed the expression of β-catenin after ISG15 gene knockout. Results We detected the protein expression of ISG15 in the cold area of Northeast China, and found that the expression of ISG15 increased in patients with psoriasis, and the proliferation of keratinocytes and the expression of β-catenin decreased in psoriasis cell model after ISG15 was knocked down. ISG15 regulates keratinocyte proliferation through Wnt signaling pathway in psoriasis. Conclusions ISG15 expression is increased in psoriatic cells and skin lesions of patients with psoriasis. In psoriasis, ISG15 promotes keratinocyte proliferation through the Wnt signaling pathway.

Keywords

psoriasis / keratinocyte proliferation / ISG15 / Wnt signaling pathway

References

[1] Mease P, Palmer J, Hur P, et al. Utilization of the validated psoriasis epidemiology screening tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based corrona psoriasis registry. J Eur Acad Dermatol Venereol, 2019; 33(5): 886-892. doi: 10.1111/jdv.15443

[2] De Simone C, Caldarola G, Moretta G, et al. Moderate-to-severe psoriasis and pregnancy: impact on fertility, pregnancy outcome and treatment perspectives. G Ital Dermatol Venereol, 2019; 154(3): 305-314.

[3] Parisi R, Iskandar I, Kontopantelis E, et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ, 2020; 369: m1590.

[4] Tokuyama M, Mabuchi T. New treatment addressing the pathogenesis of psoriasis. Int J Mol Sci, 2020; 21(20): 7488. doi: 10.3390/ijms21207488

[5] Girolomoni G, Strohal R, Puig L, et al. The role of IL-23 and the IL-23/ T 17 immune axis in the pathogenesis and treatment of psoriasis. J Eur Acad Dermatol Venereol, 2017, 31(10): 1616-1626. doi: 10.1111/jdv.14433

[6] Hawkes J E, Chan T C, Krueger J G. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol, 2017; 140(3): 645-653. doi: 10.1016/j.jaci.2017.07.004

[7] Yong L, Yu Y, Li B, et al. Calcium/calmodulin-dependent protein kinase IV promotes imiquimod-induced psoriatic inflammation via macrophages and keratinocytes in mice. Nature commun, 2022; 13(1): 4255. doi: 10.1038/s41467-022-31935-8

[8] Juncker M, Kim C, Reed R, et al. ISG15 attenuates post-translational modifications of mitofusins and congression of damaged mitochondriain ataxia telangiectasia cells. Biochim Biophys Acta Mol Basis Dis, 2021; 1867( 6): 166102. doi: 10.1016/j.bbadis.2021.166102

[9] Perng Y C, Lenschow D J. ISG15 in antiviral immunity and beyond. Nat Rev Microbiol, 2018; 16(7): 423-439. doi: 10.1038/s41579-018-0020-5

[10] Raposo R A, Gupta R, Abdel-Mohsen M, et al. Antiviral gene expression in psoriasis. J Eur Acad Dermatol Venereol, 2015; 29(10): 1951-1957. doi: 10.1111/jdv.13091

[11] Gao L, Shen J, Ren Y, et al. Discovering novel hub genes and pathways associated with the pathogenesis of psoriasis. Dermatol Ther, 2020; 33(6): e13993.

[12] Lu Y, Chen Y, Shi N, et al. L36G is associated with cutaneous antiviral competence in psoriasis. Front Immunol, 2022; 13: 971071. doi: 10.3389/fimmu.2022.971071

[13] Ma J Y, Shao S, Wang G. Antimicrobial peptides: bridging innate and adaptive immunity in the pathogenesis of psoriasis. Chin Med J (Engl), 2020; 133(24): 2966-2975. doi: 10.1097/CM9.0000000000001240

[14] Zhou Y, Wang P, Yan B X, et al. Quantitative proteomic profile of psoriatic epidermis identifies Oas 2 as a novel biomarker for disease activity. Front Immunol, 2020; 11: 1432. doi: 10.3389/fimmu.2020.01432

[15] Chen Y, Zhang Z, Zhang Y, et al. Gene set enrichment analysis and ingenuity pathway analysis to verify the impact of Wnt signaling in psoriasis treated with Taodan granules. Am J Transl Res, 2023; 15(1): 422-434.

[16] Liu L, Zhou Y, Luo D, et al. Aberrant promoter methylation of Wnt inhibitory factor-1 gene is a potential target for treating psoriasis. Clin Immunol, 2023; 250: 109294. doi: 10.1016/j.clim.2023.109294